Detalles de la búsqueda
1.
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
Blood
; 2024 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843478
2.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318
3.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
4.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
5.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072687
6.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 52(3): 1191-1194, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771466
7.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 52(3): 1125-1141, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388854
8.
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.
Cancers (Basel)
; 16(8)2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672674
9.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
10.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533127
11.
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.
Cancers (Basel)
; 15(17)2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686635
12.
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry.
Int J Antimicrob Agents
; 62(4): 106952, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37582478
13.
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry.
EClinicalMedicine
; 58: 101939, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37041967
14.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923264
15.
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
J Hematol Oncol
; 16(1): 32, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37005697
16.
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
Int J Infect Dis
; 137: 98-110, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863310
17.
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.
Cancers (Basel)
; 14(22)2022 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428621
18.
Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia.
Clin Transl Med
; 11(2): e304, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634999
19.
Primary refractory multiple myeloma: a real-world experience with 85 cases.
Leuk Lymphoma
; 61(12): 2868-2875, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623944
20.
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.
Blood Cancer J
; 13(1): 132, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37666856